 |
| PDB ID: 2gz7 Macromolecule: REPLICASE POLYPROTEIN 1AB Source Organism: SARSr-CoV Gene names: - UniProt ID: Q6RCZ9 |
SIMILAR PATTERN OF AMINO ACIDS MAPPED TO PDBID '2gz7'
1) User may click on the DrReposER ID (the first column) to get information on the binding sites and drug molecule.2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.| DrReposER ID / Desc. | Drug | Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
|---|---|---|---|---|---|---|---|---|---|
 Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2X7H_B_PFNB1374_1 (ZINC-BINDING ALCOHOLDEHYDROGENASEDOMAIN-CONTAININGPROTEIN 2) | Fenoprofen | 4 / 4 | TYR A 54LEU A 58LEU A 57HIS A 41 | 1.65A | 23.04 | NoneNoneNoneD3F A 307 (-3.4A) | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3G0F_B_B49B9001_1 (MAST/STEM CELLGROWTH FACTORRECEPTOR) | Sunitinib | 5 / 10 | ALA A 173TYR A 182GLY A 149CYH A 145PHE A 140 | 1.49A | 19.71 | NoneNoneNoneD3F A 307 (-4.3A)None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1XWF_A_ADNA433_2 (ADENOSYLHOMOCYSTEINASE) | Adenosine | 3 / 3 | THR A 24GLU A 47HIS A 41 | 1.16A | 21.09 | NoneNoneD3F A 307 (-3.4A) | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AI8_B_HNQB255_1 (CATHEPSIN B) | Nitroxoline | 4 / 6 | GLY A 149HIS A 163HIS A 164CYH A 145 | 1.42A | 21.82 | NoneNoneD3F A 307 (-4.4A)D3F A 307 (-4.3A) | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MWY_A_YNUA1101_1 (MINERALOCORTICOIDRECEPTOR) | Eplerenone | 4 / 6 | GLN A 189CYH A 85THR A 175PHE A 181 | 1.69A | 20.53 | D3F A 307 ( 4.7A)NoneNoneNone | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F7F_A_NIOA602_1 (NICOTINATEPHOSPHORIBOSYLTRANSFERASE, PUTATIVE) | Niacin | 4 / 5 | HIS A 41ILE A 43PRO A 52ASP A 48 | 1.79A | 20.68 | D3F A 307 (-3.4A)NoneNoneNone | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5NZY_A_CE3A1103_1 (DNA CROSS-LINKREPAIR 1A PROTEIN) | Cefotaxime | 4 / 8 | THR A 98PRO A 96VAL A 73GLY A 71 | 1.12A | 22.19 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AI8_A_HNQA255_1 (CATHEPSIN B) | Nitroxoline | 4 / 7 | GLY A 149HIS A 163HIS A 164CYH A 145 | 1.46A | 21.82 | NoneNoneD3F A 307 (-4.4A)D3F A 307 (-4.3A) | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CCV_C_RFPC1205_1 (-) | Rifampicin | 5 / 12 | GLN A 192ASP A 187ARG A 188ARG A 40HIS A 164 | 1.63A | 13.63 | D3F A 307 (-3.2A)NoneNoneNoneD3F A 307 (-4.4A) | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VCE_A_RITA602_2 (CYTOCHROME P450 3A4) | Ritonavir | 4 / 6 | ARG A 40ARG A 88PHE A 66THR A 35 | 1.63A | 21.91 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1SN0_B_T44B602_1 (TRANSTHYRETIN) | Levothyroxine | 4 / 7 | LEU A 242GLU A 240ALA A 234LEU A 272 | 1.05A | 16.45 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FML_A_RTLA401_0 (RETINOL DEHYDRATASE) | Vitamin A | 5 / 12 | TYR A 54HIS A 41HIS A 164LEU A 86PHE A 181 | 1.61A | 18.65 | NoneD3F A 307 (-3.4A)D3F A 307 (-4.4A)NoneNone | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3G0F_A_B49A9001_1 (MAST/STEM CELLGROWTH FACTORRECEPTOR) | Sunitinib | 5 / 11 | ALA A 173TYR A 182GLY A 149CYH A 145PHE A 140 | 1.48A | 19.71 | NoneNoneNoneD3F A 307 (-4.3A)None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIP_C_HFGC1003_0 (PROLYL-TRNASYNTHETASE, PUTATIVE) | Halofuginone | 5 / 12 | LEU A 272GLU A 240HIS A 246THR A 111GLY A 109 | 1.53A | 19.61 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4G5J_A_0WMA1102_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | Afatinib | 4 / 7 | ILE A 43TYR A 54PRO A 52HIS A 41 | 1.39A | 21.41 | NoneNoneNoneD3F A 307 (-3.4A) |